Graves’ disease and vertebral fracture: Possible pathogenic link in postmenopausal women

Abstract

Background and ObjectiveThyrotoxicosis is associated with accelerated bone turnover and increases the risk of fractures and osteoporosis. Graves' disease is the most common cause of hyperthyroidism. However, studies that examined risk factors associated with fragility fractures only in patients with Graves' disease are limited. Here, we investigated whether the risk of vertebral fracture (VF) of postmenopausal Graves' disease patients is high and tried to identify the risk factors for VF in that population.Design and MethodsForty‐three postmenopausal women with Graves' disease were enrolled. Physical and biochemical indices, thyroid indices and bone mineral density (BMD) were measured, and lateral X‐rays were obtained to evaluate VFs. Age‐ and sex‐matched healthy individuals were enrolled as the control group (n = 86).ResultsThe prevalence of VFs (35% vs 17%, P < .05), osteoporosis (63% vs 33%, P < .01) and severe osteoporosis (40% vs 17%, P < .01) was significantly higher in the Graves' disease group. Although there was no significant difference in either thyroid hormone levels or the positive ratio of thyroid antibodies, the prevalence of thyroid‐stimulating antibody (TSAb) was significantly higher in Graves' disease patients with VF compared to without (100% vs 68%, P < .05). Multivariate logistic regression analyses adjusted for age identified Graves' disease as being associated with the presence of VFs (OR 2.72, 95% CI: 1.13‐6.54, P < .05) in postmenopausal women.ConclusionsPostmenopausal Graves' disease patients had high risks of VF and severe osteoporosis. TSAb could be involved as a risk factor for VF in postmenopausal Graves' disease.

Osteoporosis management and falls prevention in patients with haemophilia: Review of haemophilia guidelines

“…31 As such, osteoporosis is not screened routinely in PWH. While haemophilia is a relatively rare condition, there is a high prevalence of low BMD (27-69.5%) [8][9][10] and fracture (4-37%), 25 which is comparable to the prevalence of widely recognised risk factors including hyperthyroidism (63% low BMD, 35% vertebral fracture) 32 coeliac disease (49% low BMD, 25% peripheral skeleton fracture) 33,34 and rheumatoid arthritis (20% low BMD, 36% vertebral fracture). 35,36 This suggests that routine osteoporosis screening may be appropriate for certain groups of PWH (disease severity, adherence and type of prophylaxis, and age); data from the PHILEOS Study will inform on which group of PWH will benefit most from osteoporosis screening.…”

Association between thymic hyperplasia and serum calcium level in Graves’ disease

“…One possible reason for this discrepancy may be the use of TRAb instead of thyroid-stimulating antibody (TSAb) in previous studies. It is worth noting that certain investigations have demonstrated a significantly negative correlation between serum TSAb titers and lumbar vertebral bone mineral density, as well as a positively correlation with bone metabolism markers [ 29 , 30 ]. Diana et al observed that TSAb dose-dependently increased superoxide release in human embryonic kidney-293 cells.…”

Vitamin D3 Metabolism and Its Role in Temporomandibular Joint Osteoarthritis and Autoimmune Thyroid Diseases

“…Low serum levels of vitamin D 3 may increase the risk of the development of autoimmune thyroid diseases [ 12 ]. Moreover, it has also been reported that autoimmune thyroid diseases affect the bone metabolism [ 17 , 18 ].…”